Published in Vaccine Weekly, October 5th, 1998
The finding comes from a molecular analysis of antibodies produced by healthy adults in response to Streptococcus pneumoniae capsular polysaccharides (PPS).
"These studies have begun to define the genetic and functional bases of PPS-specific antibody repertoires and have established an experimental foundation for dissecting the relationship between pneumococcal antibody structure and protective function," noted Alexander H. Lucas of the Oakland Research Institute, Oakland, California.
Lucas reported data from these investigations in a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1998-10-05)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.